Sparks commentary - SIGA Technologies

Healthcare

Sparks - SIGA Technologies

More on this equity
SIGA Technologies (NASDAQ: SIGA) expands African footprint with Morocco agreement
Published by Jyoti Prakash, CFA

SIGA Technologies has entered into an agreement with the Ministry of Health in Morocco to supply its antiviral treatment TPOXX, to prepare against a potential mpox outbreak. This marks SIGA’s first commercial entry into the African continent (currently only available under emergency use protocols), following recent inroads across Europe and Asia-Pacific, as part of its strategic aim to expand its presence in international markets.

TPOXX is approved for the treatment of smallpox in SIGA’s domestic US and Canadian markets and is authorised in Europe and the UK for the treatment of all orthopoxviruses, including smallpox and mpox.

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.